## **Core Concept**
Gaucher's disease is a genetic disorder characterized by the deficiency of a specific enzyme involved in lipid metabolism. This deficiency leads to the accumulation of certain lipids within cells, particularly affecting the spleen, liver, and bone marrow. The disease is inherited in an autosomal recessive pattern.

## **Why the Correct Answer is Right**
The correct answer, **C. Glucocerebrosidase**, is right because Gaucher's disease is caused by a deficiency of the enzyme glucocerebrosidase. This enzyme is crucial for breaking down glucocerebroside, a type of lipid, into glucose and ceramide. Without sufficient glucocerebrosidase, glucocerebroside accumulates within macrophages, leading to the formation of Gaucher cells, which are characteristic of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A: Hexosaminidase A** is incorrect because its deficiency is associated with Tay-Sachs disease, a different lysosomal storage disorder that affects the breakdown of GM2 ganglioside.
- **Option B: Alpha-L-iduronidase** is incorrect because its deficiency leads to Hurler syndrome, another type of lysosomal storage disease that affects the breakdown of mucopolysaccharides.
- **Option D: Sphingomyelinase** is incorrect because its deficiency causes Niemann-Pick disease, a disorder related to the accumulation of sphingomyelin in cells.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for Gaucher's disease is that it can be treated with enzyme replacement therapy (ERT) using recombinant glucocerebrosidase, which helps to replace the deficient enzyme and alleviate symptoms. This treatment has significantly improved the management and quality of life for patients with Gaucher's disease.

## **Correct Answer: C. Glucocerebrosidase**